Eczacıbaşı Pharmaceuticals Marketing and Novartis Oncology

Eczacıbaşı Pharmaceuticals Marketing and Novartis Oncology signed an aggrement for the representation of the product in Türkiye in acromegaly, NET, GIST, KML and Lung Cancer treatment as of August 1st, 2019.

Our General Manager Canan Bademlioğlu, Novartis Oncology General Manager Pınar Üstündağ and the teams involved in the project in both companies participated in the signing ceremony held on the 17th of July.

Speaking at the signing ceremony, our General Manager Canan Bademlioğlu said, ‘This important cooperation is also coming to the fore with its compliance to our company's vision besides being parallel to our rooted past, and our responsibility towards patients and society.'

Pınar Üstündağ, the General Manager of Novartis Oncology, said, 'As Novartis Oncology, we believe that this strong cooperation with Eczacıbaşı Pharmaceuticals Marketing will make significant contributions for patients in the coming period.’

We will continue to strengthen our presence in the field of oncology and haematology in the coming period with this cooperation that is in line with our strategic growth targets.